- Companies
- Shanghai INT Medical
Shanghai INT Medical Valuation Multiples
Shanghai INT Medical is valued at $795M as of November 2026, a 4.7x revenue multiple. In the last 12 months, Shanghai INT Medical revenue was $154M.
Shanghai INT Medical Overview
About Shanghai INT Medical
Shanghai INT Medical Instruments Co Ltd engages in the design and development of medical devices used in fields including peripheral intervention, neurological intervention, cardiovascular intervention, or implantation, and the design and development of equipment and moulds used for the production of medical devices. The company operates in the Chinese Mainland, Europe, the United States, and Other countries and regions. The majority of the revenue comes from the Chinese Mainland.
Founded
2006
HQ
Employees
1.7K
Website
Financials (LTM)
EV
$722M
Valuation Multiples
Start free trialShanghai INT Medical Financials
Shanghai INT Medical reported last 12-month revenue of $154M.
In the same LTM period, Shanghai INT Medical generated $34M in net income.
Revenue (LTM)
Shanghai INT Medical P&L
In the most recent fiscal year, Shanghai INT Medical reported revenue of $160M and EBITDA of $54M.
Shanghai INT Medical is profitable as of last fiscal year, with gross margin of 60%, EBITDA margin of 34%, and net margin of 21%.
Financial data powered by Morningstar, Inc.
Shanghai INT Medical Stock Performance
Shanghai INT Medical has current market cap of $795M, and enterprise value of $722M.
Market Cap Evolution
Shanghai INT Medical's stock price is $3.80.
Shanghai INT Medical share price decreased by 0.7% in the last 30 days.
Shanghai INT Medical has an EPS (earnings per share) of $0.16.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $722M | $795M | 0.9% | -0.7% | - | - | $0.16 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialShanghai INT Medical Valuation Multiples
Shanghai INT Medical trades at 4.7x EV/Revenue multiple, and 13.2x EV/EBITDA.
EV / Revenue (LTM)
Shanghai INT Medical Financial Valuation Multiples
As of November 6, 2026, Shanghai INT Medical has market cap of $795M and EV of $722M.
Shanghai INT Medical has a P/E ratio of 23.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Shanghai INT Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Shanghai INT Medical Margins & Growth Rates
In the most recent fiscal year, Shanghai INT Medical reported gross margin of 60%, EBITDA margin of 34%, and net margin of 21%.
Shanghai INT Medical Margins
Data powered by FactSet, Inc. and Morningstar, Inc.
Shanghai INT Medical Operational KPIs
Shanghai INT Medical's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Shanghai INT Medical Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all Shanghai INT Medical competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Shanghai INT Medical
Shanghai INT Medical has acquired 1 company to date.
Last acquisition by Shanghai INT Medical was on September 11th 2026. Shanghai INT Medical acquired Valgen Medtech for undisclosed valuation.
Latest Acquisitions by Shanghai INT Medical
| Description | Valgen Medtech is a Shanghai-headquartered medical device company specializing in transcatheter solutions for mitral and tricuspid valve diseases. Products include the Valgen Mitral Valve Repair System and Tricuspid Annuloplasty Device, designed for percutaneous delivery to restore valve function in high-risk patients. The firm conducts trials in China and pursues FDA approvals for U.S. market entry. |
| HQ Country | |
| HQ City | Hangzhou |
| Deal Date | 11 Sep 2026 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Shanghai INT Medical acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Shanghai INT Medical
| When was Shanghai INT Medical founded? | Shanghai INT Medical was founded in 2006. |
| Where is Shanghai INT Medical headquartered? | Shanghai INT Medical is headquartered in China. |
| How many employees does Shanghai INT Medical have? | As of today, Shanghai INT Medical has over 1K employees. |
| Is Shanghai INT Medical publicly listed? | Yes, Shanghai INT Medical is a public company listed on HKEX. |
| What is the stock symbol of Shanghai INT Medical? | Shanghai INT Medical trades under 01501 ticker. |
| When did Shanghai INT Medical go public? | Shanghai INT Medical went public in 2019. |
| Who are competitors of Shanghai INT Medical? | Shanghai INT Medical main competitors include |
| What is the current market cap of Shanghai INT Medical? | Shanghai INT Medical's current market cap is $795M. |
| What is the current revenue of Shanghai INT Medical? | Shanghai INT Medical's last 12 months revenue is $154M. |
| What is the current EV/Revenue multiple of Shanghai INT Medical? | Current revenue multiple of Shanghai INT Medical is 4.7x. |
| What is the current net income of Shanghai INT Medical? | Shanghai INT Medical's last 12 months net income is $34M. |
| How many companies Shanghai INT Medical has acquired to date? | As of November 2026, Shanghai INT Medical has acquired 1 company. |
| What was the largest acquisition by Shanghai INT Medical? | None of the M&A deals Shanghai INT Medical has completed have disclosed valuations. |
| What companies Shanghai INT Medical acquired? | Shanghai INT Medical acquired Valgen Medtech. |
| In how many companies Shanghai INT Medical has invested to date? | Shanghai INT Medical hasn't invested in any companies yet (or none have been disclosed publicly). |
Lists including Shanghai INT Medical
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




